1994
DOI: 10.1148/radiology.191.3.8184038
|View full text |Cite
|
Sign up to set email alerts
|

Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging.

Abstract: Subtraction dynamic MR imaging may be helpful to rule out malignancy in nonpalpable breast tumors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
158
1
10

Year Published

1996
1996
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 303 publications
(175 citation statements)
references
References 0 publications
4
158
1
10
Order By: Relevance
“…Although this technique is closely related to the vascularity of the lesions, there is no direct connection between the pattern of contrast enhancement and the amount of tumor cellularity (28). In the literature, some malignant lesions, including papillary, medullary, and some intraductal carcinomas, metastatic lesions, and lymphoma, have been reported to enhance more slowly and to a lesser degree than other malignant breast tumors (29,32). Besides, some benign breast lesions may imitate malignant lesions in terms of contrast uptake pattern due to proliferative activities of hyperplastic parenchymal cells (28).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although this technique is closely related to the vascularity of the lesions, there is no direct connection between the pattern of contrast enhancement and the amount of tumor cellularity (28). In the literature, some malignant lesions, including papillary, medullary, and some intraductal carcinomas, metastatic lesions, and lymphoma, have been reported to enhance more slowly and to a lesser degree than other malignant breast tumors (29,32). Besides, some benign breast lesions may imitate malignant lesions in terms of contrast uptake pattern due to proliferative activities of hyperplastic parenchymal cells (28).…”
Section: Discussionmentioning
confidence: 99%
“…Besides, some benign breast lesions may imitate malignant lesions in terms of contrast uptake pattern due to proliferative activities of hyperplastic parenchymal cells (28). Particularly in the acute period of fat necrosis, proliferative dysplasia, and myxoid fibroadenoma, scar tissue formed very fast following surgical procedures (within first 6 months) and radiotherapy (within first 18 months) and vivid contrast uptake in the early period may be observed (32,33). In concordance with the literature, 5 malignant lesions of 35, including 2 of the medullary carcinoma, invasive mixed carcinoma, metaplastic carcinoma, and invasive lobular carcinoma revealed type 1 time signal intensity curve, as well as 5 of the fibroadenomas and one lesion of fat necrosis, were found to have type 3 curves (Figure 2, 3).…”
Section: Discussionmentioning
confidence: 99%
“…Some investigators who have concentrated on T1-weighted, time-signal intensity characteristics of gadolinium enhancement report very high specificities (83%-97%) (6,7,(17)(18)(19), but others have seen no significant difference between benign and malignant abnormalities (2,5,20). Investigators who have tried to directly compare the use of contrast enhancement kinetics to the use of architectural features have found architectural features to be superior to quantitative kinetic indices alone (13,14).…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, MRI has also proven to be useful in the assessment of the tumour response to chemotherapy (Thibault et al, 2004;Warren et al, 2004;Partridge et al, 2005;Segara et al, 2007). This good value of MRI in the evaluation of tumour response should also apply to ILC as, even though ILC is still a challenge for MRI (Kinkel and Hylton, 2001), the addition of MRI to mammography still increases the sensitivity in the detection of ILC (Gilles et al, 1994;Sittek et al, 1998) and, most importantly in the case of the response evaluation, the volumetric assessment is improved (Boetes et al, 2004;Fabre Demard et al, 2005;Caramella et al, 2007;Mann et al, 2008). This raises the question of whether patients who achieve complete clinical and imaging response could in some cases entirely avoid surgery.…”
Section: Discussionmentioning
confidence: 99%